← Leaderboards
David W Osborne
Dow Pharmaceutical Sciences
$997,306
Attributed
$997,306
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $507.9K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$997,306 · 2
By mechanism
R44$910,656 · 1
R43$86,650 · 1
Top collaborators
No co-investigators on record.
Most similar at Dow Pharmaceutical Sciences
Same institution · by research overlap
- Karl R Beutner$100,000
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationHigh Performance Liquid ChromatographyDrug Design /Synthesis /ProductionDrug Adverse EffectTetraethylammonium CompoundDrug Quality /StandardSkin Irritation /IrritantAcidity /Alkalinity